|
(11) | EP 1 210 080 A2 |
(12) |
|
|
|
|
|||||||||||||||||||||||
(54) | USE OF MONOAMINE OXIDASE INHIBITORS FOR THE MANUFACTURE OF DRUGS INTENDED FOR THE TREATMENT OF OBESITY |